flurbiprofen has been researched along with Coronary Restenosis in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maffia, P | 1 |
| Ianaro, A | 1 |
| Sorrentino, R | 1 |
| Lippolis, L | 1 |
| Maiello, FM | 1 |
| del Soldato, P | 1 |
| Ialenti, A | 1 |
| Cirino, G | 1 |
1 other study available for flurbiprofen and Coronary Restenosis
| Article | Year |
|---|---|
Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents, Non-Steroid | 2002 |